Cholinergic mechanism--monoamines relation in certain brain structures.
D000109:Acetylcholine / Q000494:pharmacology; D000613:Aminobutyrates / Q000494:pharmacology; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology; D001479:Basal Ganglia / Q000187:drug effects; D001679:Biogenic Amines / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects* / Q000201:enzymology; D002118:Calcium / Q000494:pharmacology; D002415:Cats; D002421:Caudate Nucleus / Q000187:drug effects; D000242:Cyclic AMP / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D004347:Drug Interactions; D000882:Haplorhini; D006801:Humans; D007858:Learning / Q000187:drug effects; D008568:Memory / Q000187:drug effects; D008781:Methyltyrosines / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D015032:Zinc / Q000494:pharmacology
D000613:Aminobutyrates; D000978:Antiparkinson Agents; D001679:Biogenic Amines; D008781:Methyltyrosines; D010276:Parasympatholytics; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D000242:Cyclic AMP; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D015032:Zinc; D000109:Acetylcholine; D002118:Calcium; D004298:Dopamine